BP004503: Biotinylated Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and CLGGLLTMV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/Well) on streptavidin (5 ug/ml) precoated plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Antibody protein with the C-hFc tag with the EC50 of 2.4 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004130: Biotinylated Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M)and SSCSSCPLTK peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP002498-PRO-1005: Recombinant Human Cyclin G1 (CCNG1) Protein
Source: E. coli-derived.
Purity: > 85% as determined by SDS-PAGE.BP004665: Chimeric HLA-A*02:01 (ma3) &B2M&LMP2 (CLGGLLTMV) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Chimeric HLA-A*02:01 (ma3) &B2M&LMP2 (CLGGLLTMV) Tetramer Protein, (amino acids Gly25-Thr206(Human HLA-A*02:01 a1&a2) & Asp207-Glu299(Mouse H-2Ld a3), Ile21-Met119(B2M) and CLGGLLTMV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Chimeric HLA-A*02:01(ma3)&B2M&LMP2 (CLGGLLTMV) Tetramer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Antibody protein with the C-hFc tag with the EC50 of 10.6 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004664: Chimeric HLA-A*02:01 (mα3) &B2M&LMP2 (CLGGLLTMV) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Chimeric HLA-A*02:01 (mα3) &B2M&LMP2 (CLGGLLTMV) Monomer Protein, (amino acids Gly25-Thr206(Human HLA-A*02:01 α1&α2) & Asp207-Glu299(Mouse H-2Ld α3), Ile21-Met119(B2M)and CLGGLLTMV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Chimeric HLA-A*02:01(mα3)&B2M&LMP2 (CLGGLLTMV) Monomer protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Antibody protein with the C-hFc tag with the EC50 of 5.4 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004541: Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and CLGGLLTMV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Monomer protein with the C-His-Avi tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Antibody protein with the C-hFc tag with the EC50 of 18.4 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005060: Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and CLGGLLTMV peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Tetramer protein with the C-His-Avi tag at 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) Antibody protein with the C-hFc tag with the EC50 of 5.0 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004131: Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M)and SSCSSCPLTK peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP001366-C523: Recombinant Human Kininogen-1 (KNG1) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP001778-C655: Recombinant Human Mannan-Binding Lectin Serine Protease 1 (MASP1) Enzyme
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).